Reproductive planning is an increasingly informed and personalized decision. In this context, knowing the state of the ovarian reserve is key to understanding current fertility and anticipating possible future scenarios. One of the most useful and reliable markers in clinical practice is the anti-Müllerian hormone (AMH), whose analysis provides relevant information for decision-making. 

What is the anti-Müllerian hormone (AMH)?

The anti-Müllerian hormone (AMH) is a hormone produced by the ovarian follicles. Its concentration in the blood indirectly reflects the number of available oocytes, that is, the ovarian reserve.

During a woman's reproductive life, AMH levels reach their peak and subsequently decrease progressively with age. This decline is related to the natural reduction in the number of ovarian follicles, making AMH a reliable clinical marker for both ovarian reserve and reproductive potential. 

What does the AMH test consist of?

The determination of AMH is carried out through a simple blood test, with several advantages from a clinical point of view:

• It can be performed at any time during the menstrual cycle. 
• It does not require prior fasting. 
• It offers precise and reproducible results.

It is important to note that, although the decrease in AMH is a physiological process associated with aging, in some cases this decline can accelerate, making natural conception difficult.

In addition to age, there are other factors that can influence the ovarian reserve, such as certain genetic diseases or lifestyle-associated conditions. Among them, metabolic syndrome and chronic inflammatory processes stand out, as they can negatively affect ovarian function. 

What information does AMH provide? 

The measurement of AMH has multiple 
applications in the clinical and reproductive fields. Among its main uses are:

• Evaluating ovarian reserve and fertility status. 
  
• Early detection of a possible premature ovarian insufficiency. 
  
• Identifying elevated levels that may be associated with pathologies such as polycystic ovary syndrome or granulosa cell ovarian tumors. 
  

Therefore, it is not only a quantitative marker but also an orienting tool in 
identifying relevant gynecological alterations. 

Who is this test for?

The AMH analysis can be especially useful in different 
clinical situations:

• Women who want to know their current fertility. 
  
• People who are considering planning their motherhood. 
  
• Patients with irregular periods or absence of menstruation (amenorrhea).
• Women from the age of 25 who want a preventive evaluation of their ovarian reserve. 

The information obtained allows for informed decisions about the most suitable time to seek pregnancy or to consider reproductive alternatives. 

Importance of the comprehensive clinical approach 

The interpretation of AMH levels should not be done in isolation. For a proper assessment, it is essential to integrate them with other clinical factors, such as:

• The patient's age. 
  
• Personal and reproductive clinical history. 
  
• Other complementary hormonal parameters. 

The role of the healthcare professional is fundamental to contextualize the results and offer personalized advice adapted to each case. 

 

👉 Access the test now in our eShop: 

Female Fertility Test – Anti-Müllerian Hormone (AMH)